Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)
| 5.81 Data as of Jan 30 |  -0.05 / -0.85%Today’s Change | 4.20 Today|||52-Week Range 6.20 | -2.84% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 45.9M | 51.1M | 48.9M | 32.0M | |
| Cost of Goods Sold | 3.6M | 5.4M | 5.0M | 5.4M | ||
| Depreciation And Amortization | 978.4K | 1.0M | 901.6K | 1.3M | ||
| Operating Expenses | Gross Income | 41.3M | 44.7M | 42.9M | 25.3M | |
| General Expenses | 34.7M | 34.8M | 34.1M | 29.1M | ||
| Other Operating Expenses | 108.9K | 109.3K | 0.00 | 0.00 | ||
| Research And Development | 4.3M | 5.0M | 5.1M | 5.6M | ||
| Total Operating Expenses | 39.4M | 41.3M | 40.0M | 35.8M | ||
| Non-Operating Expenses | Operating Income | 6.5M | 9.8M | 8.8M | -3.8M | |
| Extraordinary Charge | 0.00 | -100.0K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 1.4M | 253.5K | 72.0K | 103.4K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 5.3M | 9.7M | 9.1M | -3.7M | |
| Income Taxes | -2.9M | -4.1M | -3.2M | -1.5M | ||
| Minority Interest | -29.7K | -31.3K | -36.3K | -46.8K | ||
| Net Income | 2.5M | 5.7M | 5.8M | -2.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 20.3M | 20.3M | 19.6M | 18.3M | |
| Shares To Calculate EPS Diluted | 21.1M | 20.6M | 19.8M | 18.3M | ||
| Earnings Per Share | EPS | $0.12 | $0.28 | $0.30 | -$0.11 | |
| EPS Diluted | $0.12 | $0.28 | $0.30 | -$0.11 | ||
.